Tag Archives: medical laser

Pioneering study confirms benefits of Modulight’s technology and photoimmunotherapy for ovarian cancer

A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight’s laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. “We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight's laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. "We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →

Vision-sparing targeted phototherapy for uveal melanoma

Preliminary investigation of AU-011     Related Modulight products and Services   Related Publications Virus-Like Particle-Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens Rhonda C. Kines, Cynthia D. Thompson, Sean Spring, Zhenyu Li, Elisabet de los Pinos, Stephen Monks and John T. Schiller Cancer Immunology Research, 2021, 9 (6)   A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma Prithvi Mruthyunjaya, Amy C. Schefler, Ivana K. Continue reading →Customer case Aura Biosciences, headquartered in Cambridge, MA, is developing a new class of photoactivated therapy for cancer patients together with National Cancer Institute, Emory Eye Center and Wills Eye Hospital. The therapy is based on virus-like conjugates and its primary indication is uveal melanoma. The goal is to eventually develop this technology for multiple cancer indications, such as non-muscle invasive bladder cancer (NMIBC), for which plans are underway to conduct a clinical trial. Dr. Carol Shields, MD – Aura Biosciences Dr. Rhonda Kines, PhD – Continue reading →

Modulight becomes exclusive supplier for BAUSCH + LOMB

BRIDGEWATER, N.J., December 04, 2018 – Bausch + Lomb, a leading global eye health company, and Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, announced the companies have entered into an exclusive agreement to collaborate and develop a new photodynamic laser specifically designed for use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) therapy. “Photodynamic therapy continues to be an important option for eye care professionals who treat choroidal neovascularization in patients who suffer from persistent disease activity, but the availability of lasers capable Continue reading →

Workshop: Personalized medicine for better life

Time: Wed 15.6.2016, 8:30–11:00 Place:  Hotel Kämp, Helsinki  Paavo Nurmi cabinet  Pohjoisesplanadi 29, Helsinki, Finland   Confirmed speakers Lecture slideshows   Click here to view our previous workshop at ASLMS-2015. Related products: ML7710 – the tool for professionals »   |   Products for oncology »   |   ML8500 automatic illumination system »   | Illumination kit  »Time: Wed 15.6.2016, 8:30–11:00 Place:  Hotel Kämp, Helsinki  Paavo Nurmi cabinet  Pohjoisesplanadi 29, Helsinki, Finland   Confirmed speakers   Prof. Eero Mervaala: Optogenetics in cardiology and cardiotoxicity Professor, Pharmacology, University of Helsinki Professor Mervaala works in the field of cardiovascular and metabolic pharmacology in the Department of Pharmacology, University of Helsinki, Finland. Prof. Teuvo Tammela: Prostate cancer therapy with laser as part of combinatory treatment Professor in Urology, Tampere University Dr. Teuvo Tammela is a specialist in urology and surgery. He is a meritorious scientist especially Continue reading →

Protected: Workshop on the best practices in clinical photodynamic therapy Password Protected

There is no excerpt because this is a protected post.Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Topics PDT dosimetry – Dr. Gal Shafirstein, Roswell Park Cancer Center, Buffalo, NY [embeddoc url="https://modulight.com/wp-content/uploads/2015/08/ASMLS-2015-PDT-Workshop-Prof.-Shafirstein-Final.pptx" width="280px" height="210px" download="all" viewer="microsoft"] Head & Neck – Dr. Merrill Biel, University of Minnesota Medical School, Minneapolis, MN Cholangiocarsinoma & Esophageal – Dr. Herbert C. Wolfsen, Mayo Clinic, Jacksonville, FL [embeddoc url="https://modulight.com/wp-content/uploads/2015/08/ASLMS_2015_Jones-Wolfsen.pptx" width="280px" height="210px" download="all" viewer="microsoft] Thoracic PDT – Dr. Patrick Ross Jr, The Ohio State University, Columbus, OH Mesothelioma – Dr. Keith Cengel, Perelman School of Medicine, Philadelphia, PA Breast – Dr. Continue reading →

Modulight launches the world’s first multi indication CE and ETL certified medical laser

Tampere, January 28, 2015 – Modulight, Inc., a leading biomedical laser manufacturer announced today ML7710 laser platform launch and certification. Unlike other lasers in the industry Modulight ML7710 has been certified and supports a wide range of indications and configurations. Medical CE and ETL marking are valid for all multi-channel (1–8 outputs) laser configurations between 400–2000nm and up to 15W vs. typical application and wavelength specific support. ML7710 supports directly several laser based treatment modalities, like photodynamic therapy (PDT), laser surgery, photo disinfection, and photo coagulation. This saves Continue reading →

Oncology

[slideshow_deploy id=’488′] Oncology Modulight laser systems are ideal solution for oncology, surgery & bacteria removal (photo disinfection). In Photodynamic therapy (PDT) alone – tens of hospitals use our systems. Our ML7710 is the most configurable laser platform in the world and boasts a unique platform approval. It boasts up to 8 channels, multiple wavelengths, tens of Watts optical power from 400 to 2000nm. All platform certification to accelerate your product development or clinical trials. Our systems boast unparalleled flexibility and ease-of-use. Produts are supported with Continue reading →[slideshow_deploy id='488'] Oncology Modulight laser systems are ideal solution for oncology, surgery & bacteria removal (photo disinfection). In Photodynamic therapy (PDT) alone – tens of hospitals use our systems. Our ML7710 is the most configurable laser platform in the world and boasts a unique platform approval. It boasts up to 8 channels, multiple wavelengths, tens of Watts optical power from 400 to 2000nm. All platform certification to accelerate your product development or clinical trials. Our systems boast unparalleled flexibility and ease-of-use. Produts are supported with Continue reading →

Medical laser system ML7710 – Tool for professionals

ML7710Laser Platform for Clinical UseML7710 is the most versatile multichannel, multi-indication and cloud connected medical laser in the world. ML7710 supports all known photosensitizers and user-friendly self-calibration. The treatment flow can be customized for specific needs guaranteeing ultimate patient safety and comfort.Perfect laser for clinical and pre-clinical applications ML7710 is a cloud-connected clinical laser platform, suitable for various medical applications, ranging from photodynamic therapy to fluorescence imaging and photothermal therapy. The system can be equipped with up to eight (8) laser outputs on same or Continue reading →

Workshop on photodynamic therapy

Sat 7th Feb 5.30–9 pm Downtown San Francisco Topics • Discuss possible ways for enhancing the dissemination of PDT for cancer therapy – Prof. Gal Shafirstein, Roswell Park CI • Scope of active clinical studies in PDT – Prof. Keith Cengel, Univ. of Pennsylvania • Diagnosis, fluorescence and spectroscopy – Prof. Brian Pogue, Dartmouth College • Is dose planning enough or should we use online treatment monitoring? – Prof. Timothy Zhu, Univ. of Pennsylvania • Will multiple channel and/or multiple wavelength lasers make our life easier? – Dr. Timothy Baran, Continue reading →Sat 7th Feb 5.30–9 pm Downtown San Francisco Topics • Discuss possible ways for enhancing the dissemination of PDT for cancer therapy – Prof. Gal Shafirstein, Roswell Park CI • Scope of active clinical studies in PDT – Prof. Keith Cengel, Univ. of Pennsylvania • Diagnosis, fluorescence and spectroscopy – Prof. Brian Pogue, Dartmouth College • Is dose planning enough or should we use online treatment monitoring? – Prof. Timothy Zhu, Univ. of Pennsylvania • Will multiple channel and/or multiple wavelength lasers make our life easier? – Dr. Timothy Baran, Continue reading →

Workshop on the best practices in clinical photodynamic therapy

Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Workshop presentations Products and accessories on display • ML7710 – CE and ETL marked multi-purpose PDT laser platform • ML6700 – PDT-Illumination laser module tailored to PDT for R&D • ML6600 – Multi-wavelength laser module for PDT • External dose calibration module for PDT lasers NEW • Hand pieces for superficial PDT illumination NEW • Tailored PC software for PDT laser modules Speakers’ biographies   Click here to view our previous workshop at PW-2015. Related products: ML7710 – the tool for professionals »   |   Continue reading →Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Workshop presentations PDT dosimetry – Dr. Gal Shafirstein, Roswell Park Cancer Center, Buffalo, NY [embeddoc url=”https://modulight.com/wp-content/uploads/2015/08/ASMLS-2015-PDT-Workshop-Prof.-Shafirstein-Final.pptx” width=”280px” height=”210px” download=”all” viewer=”microsoft”] Head & Neck – Dr. Merrill Biel, University of Minnesota Medical School, Minneapolis, MN Cholangiocarsinoma & Esophageal – Dr. Herbert C. Wolfsen, Mayo Clinic, Jacksonville, FL [embeddoc url=”https://modulight.com/wp-content/uploads/2015/08/ASLMS_2015_Jones-Wolfsen.pptx” width=”280px” height=”210px” download=”all” viewer=”microsoft] Thoracic PDT – Dr. Patrick Ross Jr, The Ohio State University, Columbus, OH Mesothelioma – Dr. Keith Cengel, Perelman School of Medicine, Philadelphia, PA Breast – Continue reading →